Fewer ophthalmologists equals less diabetic eye care

April 15, 2014
Fewer ophthalmologists equals less diabetic eye care

(HealthDay)—In areas with less access to ophthalmologists, fewer individuals with diabetes, diabetic retinopathy, and age-related macular degeneration (ARMD) receive care, according to a study published in the April issue of JAMA Ophthalmology.

Diane M. Gibson, Ph.D., from Baruch College-City University of New York in New York City, utilized data from the 2005 to 2008 National Health and Nutrition Examination Survey to identify 1,098 individuals with diabetes, 345 with diabetic retinopathy, and 498 with ARMD (all ≥40 years of age).

The researchers found that individuals who lived in a county in the highest ophthalmologist availability quartile were less likely to be unaware they had diabetic retinopathy (predictive margin [PM], 66.1 versus 84.1 percent). They were also less likely to have vision-threatening diabetic retinopathy (PM, 1.4 versus 2.6 percent), compared to individuals who lived in a county in the lower three quartiles of ophthalmologist availability. Those living in a county in the lowest quartile of ophthalmologist availability were more likely to be unaware they had ARMD (PM, 93.8 versus 88.3 percent), compared to those living in a county in the higher three quartiles of ophthalmologist availability. No outcomes were significantly tied to optometrist availability quartiles.

"Adequate access to ophthalmologists is necessary to ensure that this large number of individuals at high risk of and already affected by or ARMD have the best visual health outcomes possible," Gibson writes.

Explore further: Diabetic retinopathy severity inversely tied to cognition

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Diabetic retinopathy severity inversely tied to cognition

July 1, 2013
(HealthDay)—For patients with type 2 diabetes, the severity of diabetic retinopathy (DR) is inversely linked to cognitive impairment, according to a study published online April 30 in Diabetes Care.

Retinopathy severity linked to cardiovascular outcome

January 25, 2013
(HealthDay)—For individuals with type 2 diabetes, incident cardiovascular outcomes are determined not only by the severity of diabetic retinopathy but also by its progression, according to research published online Dec. ...

Monoclonal antibody effective therapy for diabetic retinopathy

October 7, 2012
(HealthDay)—An antibody can reduce retinal vascular leakage and inflammation in rat models of diabetic retinopathy, according to a study published online Oct. 1 in Diabetes.

Recommended for you

Study advances gene therapy for glaucoma

January 16, 2018
While testing genes to treat glaucoma by reducing pressure inside the eye, University of Wisconsin-Madison scientists stumbled onto a problem: They had trouble getting efficient gene delivery to the cells that act like drains ...

New study offers added hope for patients awaiting corneal transplants

January 9, 2018
New national research led by Jonathan Lass of Case Western Reserve University School of Medicine has found that corneal donor tissue can be safely stored for 11 days before transplantation surgery to correct eye problems ...

Diabetic blindness caused and reversed "trapped" immune cells in rodent retinas

January 3, 2018
Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels ...

Ophthalmologists increasingly dissatisfied with electronic health records

December 29, 2017
Ophthalmologists' use of electronic health records (EHR) systems for storing and accessing patients' medical histories more than doubled between 2006 and 2016, while their perceptions of financial and clinical productivity ...

Higher omega-3 fatty acid intake tied to lower glaucoma risk

December 26, 2017
(HealthDay)—Increased daily intake of ω-3 fatty acids is associated with lower odds of glaucoma, but higher levels of total polyunsaturated fatty acid (PUFA) intake are associated with higher odds of developing glaucoma, ...

Protein analysis allows for treatment of eye-disease symptoms with existing drugs

December 21, 2017
Demonstrating the potential of precision health, a team led by a researcher at the Stanford University School of Medicine has matched existing drugs to errant proteins expressed by patients with a rare eye disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.